Skip to main content

Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Related professionals

M Jesus Arevalo  Navines

M Jesus Arevalo Navines

Postdoctoral researcher
Clinical Neuroimmunology
Read more
Ester Palacio Gutierrez

Ester Palacio Gutierrez

Research technician
Liver Diseases
Read more
Marisol Ruiz Meana

Marisol Ruiz Meana

Main researcher
Cardiovascular Diseases
Read more
Olga Luengo Sanchez

Olga Luengo Sanchez

Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.